Long-term, Safety and Tolerability Study of AFQ056 in Adolescent Patients With Fragile X Syndrome (Open-label)
Clinical trial NCT01433354 · TERMINATED
Trial details
- NCT number
- NCT01433354
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2014-09-01
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.